Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06269510
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-03-26
First Post:
2024-02-13
Brief Title:
Enhancing Alcohol Treatment Engagement in Associated Liver Disease ALD Patients
Sponsor:
University of Michigan
Organization:
University of Michigan
Study Overview
Official Title:
Enhancing Alcohol Treatment Engagement in ALD Patients
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this trial is to see if providing patients with alcohol-related liver disease with tailored alcohol use treatment options will increase engagement with treatment and correct possible misconceptions
Detailed Description:
Eligible participants will be randomized to stage 1 of treatment which consists of a previously pilot-tested behavioral application app the ENGAGE-ALD app consisting of a knowledge improvement module and a preference-sensitive treatment matching module Those who do not engage in AUD treatment after randomization non-responders will be re-randomized at 3-months and continue on this in stage two if considered a responder met treatment engagement Participants that were not considered to have met treatment engagement will be re-randomized at 3-months to a Treatment Facilitation bundle consisting of a barriers to treatment survey followed by a health coaching session
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 1R01AA030748-01 | NIH | None | httpsreporternihgovquickSearch1R01AA030748-01 |